mlsanityData to 14 Oct 2026

Rate doubly robust estimation for weighted average treatment effects

arXiv 2509.14502 ↗First posted 18 Sep 2025stat.ME math.ST stat.MLcited by 0

Not on the map. Why?

Abstract (arXiv)

The weighted average treatment effect (WATE) defines a versatile class of causal estimands for populations characterized by propensity score weights, including the average treatment effect (ATE), treatment effect on the treated (ATT), on controls (ATC), and for the overlap population (ATO). WATE has broad applicability in social and medical research, as many datasets from these fields align with its framework. However, the literature lacks a systematic investigation into the robustness and efficiency conditions for WATE estimation. Although doubly robust (DR) estimators are well-studied for ATE, their applicability to other WATEs remains uncertain. This paper investigates whether widely used WATEs admit DR or rate doubly robust (RDR) estimators and assesses the role of nuisance function accuracy, particularly with machine learning. Using semiparametric efficient influence function (EIF) theory and double/debiased machine learning (DML), we propose three RDR estimators under specific rate and regularity conditions and evaluate their performance via Monte Carlo simulations. Applications to NHANES data on smoking and blood lead levels, and SIPP data on 401(k) eligibility, demonstrate the methods' practical relevance in medical and social sciences.

Key facts. No citing papers in the map yet (data through 14 Oct 2026). Builds on 30 of its 95 references that are in the map. First posted on arXiv 18 Sep 2025.

Builds on

30 of 95 references.

References · 30

  1. 2016Balancing Covariates via Propensity Score Weightingcited by 65
  2. 2022Doubly Robust Calibration of Prediction Sets under Covariate Shiftcited by 40
  3. 2013Robust Inference on Average Treatment Effects with Possibly More Covariates than Observationscited by 38
  4. 2020Elastic Integrative Analysis of Randomized Trial and Real-World Data for Treatment Heterogeneity Estimationcited by 17
  5. 2021Federated Adaptive Causal Estimation (FACE) of Target Treatment Effectscited by 16
  6. 2018Robust Inference Using Inverse Probability Weightingcited by 14
  7. 2023Data thinning for convolution-closed distributionscited by 13
  8. 2024Multi-Source Conformal Inference Under Distribution Shiftcited by 11
  9. 2020Propensity score weighting under limited overlap and model misspecificationcited by 8
  10. 2020Improving trial generalizability using observational studiescited by 7
  11. 2022Doubly robust estimators for generalizing treatment effects on survival outcomes from randomized controlled trials to a target populationcited by 7
  12. 2015Propensity Score Matching and Subclassification in Observational Studies with Multi-level Treatmentscited by 6
18 more
  1. 2017On Adaptive Propensity Score Truncation in Causal Inferencecited by 6
  2. 2022Double Machine Learning Methods for Estimating Average Treatment Effects: A Comparative Studycited by 6
  3. 2024Who Are We Missing? A Principled Approach to Characterizing the Underrepresented Populationcited by 6
  4. 2015A subsampled double bootstrap for massive datacited by 5
  5. 2020Propensity Score Weighting for Causal Subgroup Analysiscited by 3
  6. 2020PSweight: An R Package for Propensity Score Weighting Analysiscited by 3
  7. 2021Propensity Score Weighting Analysis of Survival Outcomes Using Pseudo-observationscited by 3
  8. 2022Overlap, matching, or entropy weights: what are we weighting for?cited by 3
  9. 2023Average treatment effect on the treated, under lack of positivitycited by 3
  10. 2024Heavy Tail Robust Estimation and Inference for Average Treatment Effectscited by 3
  11. 2022Variance estimation for the average treatment effects on the treated and on the controlscited by 2
  12. 2023Using Overlap Weights to Address Extreme Propensity Scores in Estimating Restricted Mean Counterfactual Survival Timescited by 1
  13. 2023Real Effect or Bias? Best Practices for Evaluating the Robustness of Real-World Evidence through Quantitative Sensitivity Analysis for Unmeasured Confoundingcited by 1
  14. 2024A Unified Framework for Causal Estimand Selectioncited by 1
  15. 2025COADVISE: Covariate Adjustment with Variable Selection in Randomized Controlled Trialscited by 1
  16. 2025Targeted Data Fusion for Region-Specific Survival Effects in the AMP HIV Prevention Trialscited by 1
  17. 2025Integrating Randomized Controlled Trial and External Control Data Using Balancing Weights: A Comparison of Estimands and Estimatorscited by 1
  18. 2025Variance Estimation for Weighted Average Treatment Effectscited by 1

Built on by

Not cited yet.